Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

142844-00-6

File Name: duniway_com---msds-vhs-htr-ins.asp
                                                                                       Duniway Part #: VHS-HTR-INS

ZIRCAR Fibrous Ceramics

MATERIAL SAFETY DATA SHEET
No.: MSDS-71
Date Prepared: 3/89

Rev. No.: 5
Date Revised: 1/95

I. PRODUCT IDENTIFICATION
Trade Name(s): LUMINAR CERAMIC PAPER,ASPA-1,ASPA-2
MILLBOARD, 1260-MBA, 1260-MBB
Synonym: CERAMIC PAPER; REFRACTORY PAPER; MILLBOARD
UN Number: NA
Chemical Family: METAL OXIDES - CERAMIC Formula:
MIXTURE
Manufacturer: ZIRCAR PRODUCTS INC.
Telephone: (914)651-4481
Address: P.O. BOX 458
Emergency: Same
FLORIDA, NY 10921-0458

II. HAZARDOUS INGREDIENTS
INGREDIENT NAME CAS NUMBER % EXPOSURE LIMI TS
REFRACTORY CERAMIC FIBER 142844-00-6 94-100 OSHA Proposed Exposure
Guidelines - 1 fiber/cc
ACRYLIC LATEX 0-6 SEE ATTACHMENT 1


III. PHYSICAL DATA
Appearance and Odor: WHITE TO OFF WHITE, FIBROUS PAPER OR BOARD, ODORLESS
Boiling Point: NA
Viscosity: NA
Water Solubility: INSOLUBLE
Melting Point: ABOVE 2500 F

Evaporation Rate (NA = 1): NA Specific Gravity (water = 1): 2. % Volatile by Volume: 6 pH: NA


IV. FIRE AND EXPLOSION DATA
Flash Point (Method): NONFLAMMABLE
Flammable Limits: LEL: NA UEL: NA
Extinguishing Media: NA
Unusual Fire or Explosion Hazards: NONE
NFPA Flammable/Combustion Liquid Classification: NA Auto Ignition Temperature: NA

Special Fire-Fighting Procedures: NONE

V. HEALTH HAZARDS A. Summary/Risks
Summary: DURING INSTALLATION IT IS COMMON TO CUT AND HANDLE THIS MATERIAL. THIS PROCESS MAY GENERATE DUST, THE
USE OF APPROPRIATE RESPIRATORY PROTECTION AND MECHANICAL VENTILATION IS RECOMMENDED TO KEEP EXPOSURE BELOW THE
RECOMMENDED LEVELS.
FOR MORE INFORMATION SEE SECTION IX (A) -
SPECIAL PRECAUTIONS.
Medical conditions which may be aggravated: PRE-EXISTING UPPER RESPIRATORY
AND LUNG DISEASES MAY BE AGGRAVATED.
Target Organ(s): LUNGS, SKIN AND EYES.
Acute Health Effects:PRODUCT MAY BE A MECHANICAL IRRITANT TO
SKIN, EYES AND UPPER RESPIRATORY SYSTEM.
Chronic Health Effects: SEE SECTION IX - SPECIAL PRE CAUTIONS.
Primary Entry Route(s): INHALATION, INGESTION, AND SXIN CONTACT.

V. HEALTH HAZARDS B. Signs/Symptoms of Overexposure
Inhalation: MAY CAUSE IRRITATION OR SORENESS IN THROAT AND NOSE. IN EXTREME EXPOSURES SOME CONGESTION MAY OCCUR.
Skin Contact: MAY CAUSE TEMPORARY DRYNESS, IRRITATION OR RASH. Ingestion: MAY CAUSE GASTROINTESTINAL DISTURBANCES.
Eyes: MAY CAUSE TEMPORARY IRRITATION OR INFLAMMATION.
LUMINAR CERAMIC PAPER ASPA-1 ASPA-2 MILLBOARD 1260MBA 1260-MBB

V. -HEALTH HAZARDS
MSDS-71

Rev: 5 / Page 2

C. First Aid/Emergency Procedures
Inhalation: REMOVE TO FRESH AIR. DRINK WATER TO CLEAR THROAT. BLOW NOSE TO
EVACUATE DUST.
Skin Contact: WASH WITH SOAP AND WATER, USE OF SKIN CREAM OR LOTION MAY BE
HELPFUL.
Ingestion: DO NOT INDUCE VOMITING. SEER MEDICAL ATTENTION IF NECESSARY.
Eyes: DO NOT RUB EYES, FLUSH WITH COPIOUS QUANTITIES OF WATER.
CONSULT A PHYSICIAN IF IRRITATION PERSISTS.

VI. REACTIVITY DATA
MATERIAL IS STABLE. chemical Incompatibilities: NONE
HAZARDOUS POLYMERIZATION WILL NOT OCCUR.

Conditions to Avoid: NONE

VII. SPILL OR LEAK PROCEDURES
Procedures for Spill/Leak:
NECESSARY.
Waste Disposal: COMPLY WITH FEDERAL, STATE LOCAL REGULATIONS.
REMOVE DUST WITH VACUUM FITTED WITH HEPA FILTER. USE DUST SUPPRESSANT If SWEEPING IS NECESSARY.

VIII. SPECIAL PROTECTION INFORMATION
Bye Protection: GOGGLES OR SAFETY GLASSES WITH SIDE SHIELDS ARE RECOMMENDED
DURING MACHINING OPERATIONS.
Protective Gloves: GLOVES ARE RECOMMENDED WHEN HANDLING.
Respiratory Protection: NIOSH OR MSHA APPROVED DUST RESPIRATORS IN COMPLIANCE
WITH OSHA STANDARD 29 CFR 1910.134.

Ventilation: USE SUFFICIENT NATURAL OR MECHANICAL VENTILATION TO
KEEP EXPOSURE LEVELS BELOW PEL/TLV WORK PLACE
EXPOSURE GUIDELINES.
Other: WEAR LOOSE FITTING, LONG SLEEVED CLOTHING WHEN
HANDLING IN A MANNER THAT LIBERATES LOOSE DUST. WASH
EXPOSED AREAS WITH SOAP AND WATER AFTER HANDLING.
WASH WORK CLOTHING SEPARATELY FROM OTHER CLOTHING;
RINSE WASHER THOROUGHLY.

IX. SPECIAL PRECAUTIONS
(A) California Proposition 65: ON JULY 1, 1990 THE STATE OF CALIFORNIA ADDED "CERAMIC FIBERS (AIRBORNE PARTICLES
OF RESPIRABLE SIZE)" TO THE LIST OF PROPOSITION 65 CHEMICALS WHICH ARE "KNOWN TO CAUSE CANCER" BY THE STATE.
PROPOSITION 55 LISTS ALL SUBSTANCES CLASSIFIED BY THE IARC AS A CATEGORY 1, 2A OR 2B CARCINOGEN.
(3) Ceramic Fiber Information: INHALATION AND INJECTION STUDIES ON LABORATORY ANIMALS HAVE PRODUCED CONFLICTING
RESULTS CONCERNING THE CARCINOGENICITY OF VITREOUS ALUMINOSILICATE FIBERS. NO DATA ARE AVAILABLE FROM HUMAN
EPIDEMIOLOGICAL STUDIES. THE INTERNATIONAL AGENCY OF RESEARCH ON CANCER (IARC) HAS RECENTLY REVIEWED THE
ANIMAL,HUMAN, AND OTHER RELEVANT EXPERIMENTAL DATA ON MAN MADE MINERAL FIBERS TO EVALUATE AND CLASSIFY THE CANCER
CAUSING POTENTIAL OF THESE MATERIALS. BASED ON ITS REVIEW, THE IARC HAS CLASSIFIED CERAMIC FIBER:S, ALONG WITH
FIBER GLASS WOOL AND MINERAL WOOL AS
GROUP 2B CARCINOGENS, POSSIBLY CARCINOGENIC TO HUMANS. PENDING RESULTS OF FURTHER STUDIES, STRICT ADHERENCE TO
RECOMMENDED SAFE WORR PRACTICES ARE ADVISED.
(C) After Service Information: AS MANUFACTURED THIS PRODUCT IS AN ALUMINOSILICATE WHICH MAY TRANSFORM UPON HEATING
TEMPERATURES IN EXCESS OF 1000 DEG. C FOR EXTENDED PERIODS OF TIME) TO NON-HAZARDOUS MULLITE AND C~ISTOBALITE
(CAS # 14464-46-1), A FORM OF CRYSTALLINE SILICA. REMOVAL OF THIS PRODUCT AFTER USE MAY GENERATE DUST.
PROLONGED OR REPEATED INHALATION OF RESPIRABLE FREE CRYSTALLINE SILICA DUST MAY CAUSE DELAYED LUNG INJURY
(SILICOSIS). THE IARC HAS CLASSIFIED CRYSTALLINE SILICA AS GROUP 2A, PROBABLE HUMAN CARCINOGEN. THERE IS
SUFFICIENT EVIDENCE OF CARCINOGENICITY IN ANIMALS, BUT LIMITED EVIDENCE IN HUMANS. OSHA'S FINAL RULE LIMIT AND
ACGIH'S TLV FOR RESPIRABLE CRISTOBALITE IS .05 mg/m3. APPROPRIATE VENTILATION AND RESPIRATORY PROTECTION
SHOULD BE PROVIDED IN COMPLIANCE WITH OSHA STANDARDS. STRICT ADHERENCE TO RECOMMENDED SAFE WORR PRACTICES IS
ADVISED.
(D) WHMIS Status: THIS IS A CLASS D2 CONTROLLED PRODUCT BASED ON AN IARC 2B CLASSIFICATION FOR CERAMIC FIBERS.
(E) SARA Section 313 Supplier Notification: THIS PRODUCT DOES NOT CONTAIN TOXIC CHEMICALS SUBJECT TO THE
REPORTING REQUIREMENTS OF THE SUPERFUND AMENDMENTS AND REAUTHORIZATION ACT OF 1986 SECTION 313 (40 CFR 372).

Prepared/Revised by: JOHN KOAR
Title: PRODUCTION ENGINEER
As os the date of preparation of this document, the foregoing
information is believed to be accurate and is provided in good faith
to comply with applicable federal and state laws. However, no
warranty or representation with respect to such information is
intended or given.
ZIRCAR PRODUCTS INC.
ATTACHMENT 1
ORGANIC BINDER SYSTEM

ACRYLIC LATEX
A. Decomposition by burning. Hazardous Gasses - CO
CO2
Small amounts of aromatic
and aliphatic hydrocarbons

The levels of the above gasses will vary with combustion conditions, oxygen level
and heat.

In unventilated areas, proper respiratory protection should be used.

B. Decomposition by heat in a starved oxygen atmosphere. Hazardous Gasses Released
-Acrylate monomer

Acrylonitril monomer

Acrylates - Detected by odor at approx. 90 ppb. The recommended exposure should be
controlled at or below 5 ppm as an 8 hr. TWA.

Skin contact (moist atmosphere) can produce skin irritation and prolonged or
repeated contact may produce skin sensitization.

Acrylonitriles - At the levels of latex add on and the small amount in the latex
polymer as received, there may be trace amounts released under extreme conditions.

OSHA PEL work place exposure is 2 ppm (8 hr. TWA), ceiling limit is
10 ppm for any 15 min. period (OSHA 1910, 1045, CFR Title 29).

If confined, limited air space and ventilation conditions exist, in-plant monitoring
should be done to insure compliance.

Search    ENTER KEYWORD
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
duniway_com---msds-apiezon-m.asp 8012-95-1
duniway_com---msds-apiezon-n.asp 8012-95-1
duniway_com---msds-apiezon-q.asp 68953-58-2
duniway_com---msds-apiezon-wax-w.asp 64741-56-6
duniway_com---msds-c5a-51001.asp 7440-50-8 7782-42-5 14808-60-7
duniway_com---msds-celva-2-brush-bottle.asp N/A
duniway_com---msds-celva-6-spray.asp N/A
duniway_com---msds-dc-150.asp N/A
duniway_com---msds-ds-454-duxseal.asp 14807-96-6 63449-39-8 61790-53-2 16389-88-1 14808-60-7
duniway_com---msds-ds-7040.asp N/A
duniway_com---msds-ds-7050.asp N/A
duniway_com---msds-dsff.asp 64742-65-0
duniway_com---msds-ep-8034-resin-hardener.asp 25068-38-6 14807-96-6 13463-67-7
duniway_com---msds-fomblin-06-6--14-6--16-6--25-6.asp 69991-67-9
duniway_com---msds-fomblin-y-hvac-25-9.asp N/A
duniway_com---msds-krytox-grease.asp 60164-51-4 9002-84-0
duniway_com---msds-mpo-180.asp 64741-88-4
duniway_com---msds-mpo-190.asp N/A
duniway_com---msds-mpo-200.asp N/A
duniway_com---msds-pentavac-5.asp N/A
duniway_com---msds-santovac-5.asp 2455-71-2
duniway_com---msds-two.asp N/A
duniway_com---msds-vhs-htr-ins.asp 142844-00-6
duniway_com---msds-y-lvac-14-6.asp N/A
duniway_com---msds-y-lvac-16-6.asp N/A
duniway_com---msds-y-lvac-25-6.asp N/A
ehs_lilly_com---msds_abciximab_solution.asp 143653-53-6 7732-18-5
ehs_lilly_com---msds_atomoxetine_hydrochloride_tablets_and_capsules.asp 82248-59-7
ehs_lilly_com---msds_calcium_carbonate_tablets.asp 471-34-1
ehs_lilly_com---msds_cefaclor_capsules_and_tablets.asp 70356-03-5
ehs_lilly_com---msds_cefaclor_for_oral_suspension.asp 70356-03-5
ehs_lilly_com---msds_cefamandole_nafate_for_injection.asp 42540-40-9 5968-11-6
ehs_lilly_com---msds_cefazolin_sodium.asp 27164-46-1
ehs_lilly_com---msds_ceftazidime_for_injection.asp 78439-06-2 5968-11-6
ehs_lilly_com---msds_cefuroxime_sodium.asp 56238-63-2 2600-73-1
ehs_lilly_com---msds_cephalexin_capsules_and_tablets.asp 23325-78-2
ehs_lilly_com---msds_dobutamine_hydrochloride_for_injection.asp 49745-95-1 69-65-8
ehs_lilly_com---msds_drotrecogin_alfa_activated_for_injection.asp 42617-41-4
ehs_lilly_com---msds_duloxetine_hydrochloride_capsules.asp 136434-34-9
ehs_lilly_com---msds_fluoxetine_hydrochloride_capsules_and_tablets.asp 56296-78-7
ehs_lilly_com---msds_fluoxetine_hydrochloride_oral_solution.asp 56296-78-7 57-50-1 56-81-5 64-17-5 65-85-0 7732-18-5
ehs_lilly_com---msds_gemcitabine_hydrochloride_for_injection.asp 122111-03-9
ehs_lilly_com---msds_glucagon_for_injection.asp 16941-32-5 63-42-3
ehs_lilly_com---msds_heparin_sodium_injection.asp 9041-08-1 100-51-6 7732-18-5
ehs_lilly_com---msds_insulin_human.asp 11061-68-0 9009-65-8 56-81-5 108-39-4
ehs_lilly_com---msds_insulin_lispro.asp 133107-64-9 56-81-5 7558-79-4 108-39-4 108-95-2 9009-65-8 1314-13-2 7732-18-5
ehs_lilly_com---msds_insulin_pork.asp 12584-58-6 9009-65-8 56-81-5 108-39-4 99-76-3 108-95-2 7732-18-5
ehs_lilly_com---msds_methenamine_tablets.asp 100-97-0 2029-05-8
ehs_lilly_com---msds_nortriptyline_hydrochloride_capsules_and_tablets.asp 894-71-3
ehs_lilly_com---msds_nortriptyline_hydrochloride_oral_solution.asp 894-71-3 64-17-5 7732-18-5

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com | Ads link:HBCCHEM.INC